Back
ESC Premium Access

Effect of empagliflozin as add-on therapy on serum uric acid level in patients with type 2 diabetes hospitalized for acute decompensated heart failure: a prospective randomized controlled study

Session: Poster Session 6 - Acute heart failure
Topic: Pharmacotherapy
Speaker: Mr S. Tamaki (Ehime, JP)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Mr Shunsuke Tamaki

Ehime University, Ehime (Japan)
0 follower

9 more presentations in this session

Pathway optimization for acute heart failure: seeing a cardiologist may decrease in-hospital mortality

Speaker: Doctor J. GORLICKI (Paris, FR)

Access
Like
Thumbnail

Clinical and prognostic relevance of increased liver stiffness coupled with abnormal liver function tests in decompensated heart failure

Speaker: Associate Professor A. Soloveva (Saint Petersburg, RU)

Access
Abstract
Slides
Like
Thumbnail

Impact of the albumin level on the prognostic value of diuretic response in patients admitted for acute decompensated heart failure: a prospective study

Speaker: Doctor K. Yamamoto (Osaka, JP)

Access
Abstract
Like
Thumbnail

Body-composition analysis of patients with acute heart failure -preliminary results from the SCALE HF trial-

Speaker: Mr F. De Ieso (Basel, CH)

Access
Abstract
Slides
Like
Thumbnail

Initiating angiotensin receptor blockade and neprilysin inhibitor (ARNI) in acute heart failure with mechanical support

Speaker: Assistant Professor H. Hsin (New Taipei, TW)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 6 - Acute heart failure

Speakers: Mr S. Tamaki, Doctor J. GORLICKI, Associate Professor A. Soloveva, Doctor K. Yamamoto, Mr F. De Ieso...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources